Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers

被引:0
|
作者
Ina Hubatsch
Eva G E Ragnarsson
Per Artursson
机构
[1] Uppsala University,Department of Pharmacy
[2] Box 580,undefined
来源
Nature Protocols | 2007年 / 2卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Permeability coefficients across monolayers of the human colon carcinoma cell line Caco-2, cultured on permeable supports, are commonly used to predict the absorption of orally administered drugs and other xenobiotics. This protocol describes our method for the cultivation, characterization and determination of permeability coefficients of xenobiotics (which are, typically, drug-like compounds) in the Caco-2 model. A few modifications that have been introduced over the years are incorporated in the protocol. The method can be used to trace the permeability of a test compound in two directions, from the apical to the basolateral side or vice versa, and both passive and active transport processes can be studied. The permeability assay can be completed within one working day, provided that the Caco-2 monolayers have been cultured and differentiated on the permeable supports 3 weeks in advance.
引用
收藏
页码:2111 / 2119
页数:8
相关论文
共 50 条
  • [21] Characterization of drug permeability in Caco-2 monolayers by mass spectrometry on a membrane-based microfluidic device
    Gao, Dan
    Liu, Hongxia
    Lin, Jin-Ming
    Wang, Yini
    Jiang, Yuyang
    LAB ON A CHIP, 2013, 13 (05) : 978 - 985
  • [22] Orthogonal Chromatographic Descriptors for Modelling Caco-2 Drug Permeability
    Deconinck, E.
    Verstraete, T.
    Van Gyseghem, E.
    Heyden, Y. Vander
    Coomans, D.
    JOURNAL OF CHROMATOGRAPHIC SCIENCE, 2012, 50 (03) : 175 - 183
  • [23] Implicit solvation modeling drug permeability of Caco-2 membranes
    Elmasry, Natalie
    Kelly, Casey P.
    Cramer, Christopher J.
    Truhlar, Donald G.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233 : 121 - 121
  • [24] Accelerated Caco-2 cell permeability model for drug discovery
    Sevin, E.
    Dehouck, L.
    Fabulas-da Costa, A.
    Cecchelli, R.
    Dehouck, M. P.
    Lundquist, S.
    Culot, M.
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2013, 68 (03) : 334 - 339
  • [25] DRUG-DELIVERY STUDIES IN CACO-2 MONOLAYERS .4. ABSORPTION ENHANCER EFFECTS OF CYCLODEXTRINS
    HOVGAARD, L
    PHARMACEUTICAL RESEARCH, 1995, 12 (09) : 1328 - 1332
  • [26] Rhamnolipids enhance epithelial permeability in Caco-2 monolayers
    Jiang, Lifang
    Long, Xuwei
    Meng, Qin
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2013, 446 (1-2) : 130 - 135
  • [27] Permeability of lipophilic compounds in drug discovery using in-vitro human absorption model, Caco-2
    Krishna, G
    Chen, KWJ
    Lin, CC
    Nomeir, AA
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 222 (01) : 77 - 89
  • [28] CORRELATION BETWEEN ORAL-DRUG ABSORPTION IN HUMANS AND APPARENT DRUG PERMEABILITY COEFFICIENTS IN HUMAN INTESTINAL EPITHELIAL (CACO-2) CELLS
    ARTURSSON, P
    KARLSSON, J
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 175 (03) : 880 - 885
  • [29] Drug delivery studies in Caco-2 monolayers. VI. Studies of enzyme substitution therapy for phenylketonuria - a new application of Caco-2 monolayers
    Hovgaard, L
    Jorgensen, SW
    Eigtved, P
    Frokjaer, S
    Brondsted, H
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1998, 161 (01) : 109 - 114
  • [30] Cytotoxicity of absorption enhancers in Caco-2 cell monolayers
    Sakai, M
    Imai, T
    Ohtake, H
    Otagiri, M
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 1998, 50 (10) : 1101 - 1108